Lipoprotein changes in HIV-infected antiretroviral-naïve individuals after starting antiretroviral therapy: ACTG Study A5152s

« Previous Next »Journal of Clinical Lipidology
Volume 2, Issue 6 , Pages 464-471, December 2008

James H. Stein, MD, FAHA
- University of Wisconsin School of Medicine and Public Health, 600 Highland Avenue, G7/341 CSC (MC 3248), Madison, WI 53792, USA
- Corresponding author
Lauren Komarow, MS
- Harvard School of Public Health, Boston, MA, USA
Bruno R. Cotter, MD
- University of California-San Diego, San Diego, CA, USA
Judith S. Currier, MD
- University of California-Los Angeles, Los Angeles, CA, USA
Michael P. Dubé, MD
- Indiana University School of Medicine, Indianapolis, IN, USA
Carl J. Fichtenbaum, MD
- University of Cincinnati Medical Center, Cincinnati, OH, USA
Mariana Gerschenson, PhD
- University of Hawaii, Honolulu, HI, USA
Carol K.C. Mitchell, PhD
- University of Wisconsin School of Medicine and Public Health, 600 Highland Avenue, G7/341 CSC (MC 3248), Madison, WI 53792, USA
Robert L. Murphy, MD
- Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
Kathleen Squires, MD
- University of Southern California, Los Angeles, CA, USA
Robert A. Parker, ScD
- Harvard School of Public Health, Boston, MA, USA
Francesca J. Torriani, MD
- University of California-San Diego, San Diego, CA, USA
ACTG 5152s Study Team